Soterix Medical PainX® is a non-invasive medical device developed by physicians and researchers in NYC, as an adjunctive treatment for fibromyalgia and migraine. PainX® is designed to provide safe and effective transcranial direct current stimulation (tDCS) without the risks or complications of surgery. Clinical trials to date have demonstrated a robust effect of tDCS on patients with difficult-to-treat cases. For an overview of the peer-reviewed publications on tDCS, please see publications below.
The Soterix Medical PainX® tDCS Therapy is based on the company's industry standard neuromodulation products, tested in the leading medical centers. It is the only tDCS technology designed to clinical standards with the physician and patient experience in mind. PainX® is the only tDCS Therapy approved for the treatment of pain in the EU including, but not limited to, Fibromyalgia and Pain. The PainX® tDCS system does not need to be installed, is battery powered, and can be applied in almost any room. The award winning support team at Soterix Medical can guide your staff through set-up and training. Ongoing patient referrals and unlimited support is part of our mission to provide patients with the highest quality neuromodulation. Reach us at contact@soterixmedical.com
Guided by Soterix Medical customer support and training, and (where applicable) Neurotargeting® software, an optimal approach is selected to maximize speed of response, maximum efficacy, and durability of benefits.
Soterix Medical is the only manufacturer of clinical grade tDCS including accessories that as simple and reliable application to subjects, reducing set-up time and eliminating complications.
Patients sit comfortably during a fully automatic PainX-tDCS therapy. tDCS technology continuously monitors and adjust stimulation as needed for tolerated and constant therapy every season.
